Knee arthroplasty: Technique and management issues: A global approach to the management of DVT in total hip and knee arthroplasty

Orthopedics

Volumn 20, Issue 9, 1997, Pages 832-834

  Sculco, Thomas P ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULANT THERAPY; BLEEDING; CLINICAL TRIAL; COMPRESSION THERAPY; DEEP VEIN THROMBOSIS; EPIDURAL ANESTHESIA; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; ARTICLE; HIP PROSTHESIS; KNEE PROSTHESIS; POSTOPERATIVE COMPLICATION; THROMBOSIS;

HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; POSTOPERATIVE COMPLICATIONS; THROMBOSIS;

EID: 0031231165     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Lieberman JR, Huo MM, Hanway J, Salvati EA, Sculco TP, Sharrock NE. The prevalence of deep venous thrombosis after total hip arthroplasty with hypotensive epidural anesthesia. J Bone Joint Surg Am. 1994; 76:341-348.
2. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA. The John Charnley Award. Thrombogenesis during total hip replacement. Clin Orthop. 1995; 319:16-27.
3. Huo MH, Salvati EA, Sharrock NE, et al. Intraoperative adjusted dose heparin thromboembolic prophylaxis in primary total hip arthroplasty. Clin Orthop. 1992; 277:188-196.
4. Sharrock NE, Brien WW, Salvati EA, Mineo R, Garvin K, Sculco TP. The effect of intravenous fixed dose heparin during total hip arthroplasty on the incidence of deep vein thrombosis. A randomized, double blind trial in patients operated on with epidural anesthesia and controlled hypotension. J Bone Joint Surg Am. 1990; 72: 1456-1461.
5. Stulberg BN, Insall JN, Williams GW, Ghelman B. Deep vein thrombosis following total knee replacement: an analysis of 638 arthroplasties. J Bone Joint Surg Am. 1984; 66:194-201.
6. Maynard MJ, Sculco TP, Ghelman B. Progression and regression of deep vein thrombosis after total knee arthroplasty. Clin Orthop. 1991; 273:125-130.
7. Sharrock NE, Go G, Sculco TP, Ranawat CS, Maynard MJ, Harpel PC. Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquet. J Arthroplasty. 1995; 10:523-528.
8. Haas SB, Insall JN, Scuderi GR, Windsor RE, Ghelman B. Pneumatic sequential-compression boots compared with aspirin prophylaxis of deep vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am. 1990; 72:27-31.
9. Westrich GH, Sculco TP. Prophylaxis against deep venous thrombosis after total knee arthroplasty. Pneumatic planter compression and aspirin compared with aspirin alone. J Bone Joint Surg Am. 1996; 78:826-834.
10. Colwell CW Jr, Sjpiro TE, Trowbridge M, Stephens JW, Gardiner GA Jr, Ritter MA. Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep venous thrombosis after elective knee arthroplasty. Clin Orthop. 1995; 321:19-27.
11. Leclerc J, Desjardins L, Garrotes W, et al. A randomized trial of enoxaparin for the prevention of deep vein thrombosis after major knee surgery. Thromb Haemost. 1992; 67:417-423.
12. Spiro TE, Fitzgerald RH, Trowbridgé M, et al. Enoxaparin: a low molecular weight heparin and warfarin for the prevention of venous thromboembolic disease after elective knee replacement surgery. Blood. 1994; 10(suppl): 246:970-972.
13. Fitzgerald RH Jr. Preventing DVT following total knee replacement: a review of clinical trials. Orthopedics. 1995; 18(suppl): 10-11.